BIORCE
Pedro Coelho is an accomplished entrepreneur and executive with extensive experience in the healthcare and biotechnology sectors. Currently serving as Founder and CEO of BIORCE since February 2024, Coelho also holds advisory roles at AI4MedImaging- Medical Solutions S.A. and Kinetikos Health. Previously, Coelho was Senior Vice President at Talentmark, where the Clinical Research Organization focusing on Oncology and Cell and Gene Therapy was established, and held various positions in business development and client services at Talentmark and i-Pharm Consulting. Early career achievements include a promotion from Sales Manager to Chief Commercial Officer at Konspol Holding. Educational credentials include attendance at Harvard Medical School, the University of Pennsylvania, and completion of an undergraduate degree in Business Administration at EU Business School.
This person is not in any teams
This person is not in any offices
BIORCE
Biorce is a pioneering medtech company dedicated to revolutionizing drug development through the power of artificial intelligence (AI). We are passionate about accelerating medical advancements and improving patient outcomes. Our team comprises seasoned clinical research professionals, data scientists, and AI experts, working collaboratively to bridge the gap between cutting-edge technology and real-world clinical needs. With an unwavering commitment to revolutionize healthcare, Biorce envisions a world where all patients benefit from accelerated and cost-effective access to treatments. Our flagship product, Jarvis, stands as the pioneer Clinical AI assistant, granting universal access to clinical data at one's fingertips. Biorce is poised to redefine the landscape of healthcare, shaping a future where innovation and accessibility converge for the betterment of humanity. Join us in our mission to make a positive impact on healthcare. Learn more about our solutions and connect with our team on our LinkedIn page!